Nutrition Research
Volume 30, Issue 1 , Pages 32-39 , January 2010

Dietary green tea extract increases phase 2 enzyme activities in protecting against myocardial ischemia-reperfusion

  • Masoumeh Akhlaghi

      Affiliations

    • School of Health and Nutrition, Shiraz University of Medical Sciences, PO Box 71645-111, Shiraz, Iran
    • ,
  • Brian Bandy

      Affiliations

    • College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, SK, Canada S7N 5C9
    • Corresponding Author InformationCorresponding author. Tel.: +1 306 966 6336; fax: +1 306 966 6377.

Received 30 September 2009 ,Revised 12 November 2009 ,Accepted 13 November 2009.

References 

  1. Ross JA, Kasum CM. Dietary flavonoids: bioavailability, metabolic effects, and safety. Annu Rev Nutr. 2002;22:19–34
  2. Toufektsian MC, de Lorgeril M, Nagy N, Salen P, Donati MB, Giordano L, et al. Chronic dietary intake of plant-derived anthocyanins protects the rat heart against ischemia-reperfusion injury. J Nutr. 2008;138:747–752
  3. Peng PH, Ko ML, Chen CF. Epigallocatechin-3-gallate reduces retinal ischemia/reperfusion injury by attenuating neuronal nitric oxide synthase expression and activity. Exp Eye Res. 2008;86:637–646
  4. López-Sánchez C, Martín-Romero FJ, Sun F, Luis L, Samhan-Arias AK, García-Martínez V, et al. Blood micromolar concentrations of kaempferol afford protection against ischemia/reperfusion-induced damage in rat brain. Brain Res. 2007;1182:123–137
  5. Babu PV, Liu D. Green tea catechins and cardiovascular health: an update. Curr Med Chem. 2008;15:1840–1850
  6. Wolfram S. Effects of green tea and EGCG on cardiovascular and metabolic health. J Am Coll Nutr. 2007;26:373S–388S
  7. Townsend PA, Scarabelli TM, Pasini E, Gitti G, Menegazzi M, Suzuki H, et al. Epigallocatechin-3-gallate inhibits STAT-1 activation and protects cardiac myocytes from ischemia/reperfusion-induced apoptosis. FASEB J. 2004;18:1621–1623
  8. Potenza MA, Marasciulo FL, Tarquinio M, Tiravanti E, Colantuono G, Federici A, et al. EGCG, a green tea polyphenol, improves endothelial function and insulin sensitivity, reduces blood pressure, and protects against myocardial I/R injury in SHR. Am J Physiol Endocrinol Metab. 2007;292:E1378–E1387
  9. Yamazaki KG, Romero-Perez D, Barraza-Hidalgo M, Cruz M, Rivas M, Cortez-Gomez B, et al. Short- and long-term effects of (-)-epicatechin on myocardial ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol. 2008;295:H761–H767
  10. Modun D, Music I, Katalinic V, Salamunic I, Boban M. Comparison of protective effects of catechin applied in vitro and in vivo on ischemia-reperfusion injury in the isolated rat hearts. Croat Med J. 2003;44:690–696
  11. Hirai M, Hotta Y, Ishikawa N, Wakida Y, Fukuzawa Y, Isobe F, et al. Protective effects of EGCg or GCg, a green tea catechin epimer, against postischemic myocardial dysfunction in guinea-pig hearts. Life Sci. 2007;80:1020–1032
  12. Aneja R, Hake PW, Burroughs TJ, Denenberg AG, Wong HR, Zingarelli B. Epigallocatechin, a green tea polyphenol, attenuates myocardial ischemia reperfusion injury in rats. Mol Med. 2004;10:55–62
  13. Miwa S, Yamazaki K, Hyon SH, Komeda M. A novel method of ‘preparative’ myocardial protection using green tea polyphenol in oral uptake. Interact Cardiovasc Thorac Surg. 2004;3:612–615
  14. Na HK, Surh YJ. Modulation of Nrf2-mediated antioxidant and detoxifying enzyme induction by the green tea polyphenol EGCG. Food Chem Toxicol. 2008;46:1271–1278
  15. Chen XL, Kunsch C. Induction of cytoprotective genes through Nrf2/antioxidant response element pathway: a new therapeutic approach for the treatment of inflammatory diseases. Curr Pharm Des. 2004;10:879–891
  16. Werns SW, Fantone JC, Ventura A, Lucchesi BR. Myocardial glutathione depletion impairs recovery of isolated blood-perfused hearts after global ischaemia. J Mol Cell Cardiol. 1992;24:1215–1220
  17. Lapenna D, de Gioia S, Ciofani G, Mezzetti A, Pierdomenico SD, Di Ilio C, et al. Impaired glutathione biosynthesis in the ischemic-reperfused rabbit myocardium. FEBS Lett. 1996;391:76–78
  18. Cao Z, Zhu H, Zhang L, Zhao X, Zweier JL, Li Y. Antioxidants and phase 2 enzymes in cardiomyocytes. Chemical inducibility and chemoprotection against oxidant and simulated ischemia-reperfusion injury. Exp Biol Med (Maywood). 2006;231:1353–1364
  19. Leonard MO, Kieran NE, Howell K, Burne MJ, Varadarajan R, Dhakshinamoorthy S, et al. Reoxygenation-specific activation of the antioxidant transcription factor Nrf2 mediates cytoprotective gene expression in ischemia-reperfusion injury. FASEB J. 2006;20:2624–2626
  20. Muzolf-Panek M, Gliszczyńska-Swigło A, de Haan L, Aarts JM, Szymusiak H, Vervoort JM, et al. Role of catechin quinones in the induction of EpRE-mediated gene expression. Chem Res Toxicol. 2008;21:2352–2360
  21. Hara Y. Influence of tea catechins on the digestive tract. J Cell Biochem Suppl. 1997;27:52–58
  22. Lubet RA, Yang CS, Lee MJ, Hara Y, Kapetanovic IM, Crowell JA, et al. Preventive effects of polyphenon E on urinary bladder and mammary cancers in rats and correlations with serum and urine levels of tea polyphenols. Mol Cancer Ther. 2007;6:2022–2028
  23. Xiao H, Hao X, Simi B, Ju J, Jiang H, Reddy BS, et al. Green tea polyphenols inhibit colorectal aberrant crypt foci (ACF) formation and prevent oncogenic changes in dysplastic ACF in azoxymethane-treated F344 rats. Carcinogenesis. 2008;29:113–119
  24. Henning SM, Fajardo-Lira C, Lee HW, Youssefian AA, Go VL, Heber D. Catechin content of 18 teas and a green tea extract supplement correlates with the antioxidant capacity. Nutr Cancer. 2003;45:226–235
  25. Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. FASEB J. 2008;22:659–661
  26. Martini N, Preckel B, Thämer V, Schlack W. Can isoflurane mimic ischaemic preconditioning in isolated rat heart?. Br J Anaesth. 2001;86:269–271
  27. Ljubkovic M, Mio Y, Marinovic J, Stadnicka A, Warltier DC, Bosnjak ZJ, et al. Isoflurane preconditioning uncouples mitochondria and protects against hypoxia-reoxygenation. Am J Physiol Cell Physiol. 2007;292:C1583–C1590
  28. Li DY, Tao L, Liu H, Christopher TA, Lopez BL, Ma XL. Role of ERK1/2 in the anti-apoptotic and cardioprotective effects of nitric oxide after myocardial ischemia and reperfusion. Apoptosis. 2006;11:923–930
  29. Zor T, Selinger Z. Linearization of the Bradford protein assay increases its sensitivity: theoretical and experimental studies. Anal Biochem. 1996;236:302–308
  30. Kornberg A. Lactate dehydrogenase of muscle. Methods Enzymol. 1955;1:441–454
  31. Masini E, Pierpaoli S, Marzocca C, Mannaioni PF. Protective effects of a plant histaminase in myocardial ischaemia and reperfusion injury in vivo. Biochem Biophys Res Commun. 2003;309:432–439
  32. Fliss H, Gattinger D. Apoptosis in ischemic and reperfused rat myocardium. Circ Res. 1996;79:949–956
  33. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979;95:351–358
  34. Esterbauer H, Cheeseman KH. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol. 1990;186:407–421
  35. Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem. 1969;27:502–522
  36. White CC, Viernes H, Krejsa CM, Botta D, Kavanagh TJ. Fluorescence-based microtiter plate assay for glutamate-cysteine ligase activity. Anal Biochem. 2003;318:175–180
  37. Spencer CB, Rifkind AB. NAD(P)H: quinone oxidoreductase (DT-diaphorase) in chick embryo liver. Comparison to activity in rat and guinea pig liver and differences in co-induction with 7-ethoxyresorufin deethylase by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Biochem Pharmacol. 1990;39:327–335
  38. Deneke SM, Fanburg BL. Regulation of cellular glutathione. Am J Physiol. 1989;257:L163–L173
  39. Lu SC. Regulation of glutathione synthesis. Mol Aspects Med. 2009;30:42–59
  40. Ahuja P, Sdek P, MacLellan WR. Cardiac myocyte cell cycle control in development, disease, and regeneration. Physiol Rev. 2007;87:521–544
  41. Powers SK, Murlasits Z, Wu M, Kavazis AN. Ischemia-reperfusion-induced cardiac injury: a brief review. Med Sci Sports Exerc. 2007;39:1529–1536
  42. Zucchi R, Ghelardoni S, Evangelista S. Biochemical basis of ischemic heart injury and of cardioprotective interventions. Curr Med Chem. 2007;14:1619–1637
  43. Murphy E, Steenbergen C. Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. Physiol Rev. 2008;88:581–609
  44. Asayama J, Yamahara Y, Miyazaki H, Ohta B, Kobara M, Tatsumi T, et al. Effects of repeated ischemia on release kinetics of troponin T, creatine kinase, and lactate dehydrogenase in coronary effluent from isolated rat hearts. Int J Cardiol. 1994;44:131–135
  45. Vila-Petroff M, Salas MA, Said M, Valverde CA, Sapia L, Portiansky E, et al. CaMKII inhibition protects against necrosis and apoptosis in irreversible ischemia-reperfusion injury. Cardiovasc Res. 2007;73:689–698
  46. Foreback CC. Biochemical diagnosis of myocardial infarction. Henry Ford Hosp Med J. 1991;39:159–164
  47. Wong SS. Strategic utilization of cardiac markers for the diagnosis of acute myocardial infarction. Ann Clin Lab Sci. 1996;26:301–312
  48. Nicotera P, Leist M, Ferrando-May E. Intracellular ATP, a switch in the decision between apoptosis and necrosis. Toxicol Lett. 1998;102-103:139–142
  49. Babu PV, Sabitha KE, Shyamaladevi CS. Green tea impedes dyslipidemia, lipid peroxidation, protein glycation and ameliorates Ca2+ -ATPase and Na+/K+ -ATPase activity in the heart of streptozotocin-diabetic rats. Chem Biol Interact. 2006;162:157–164

PII: S0271-5317(09)00243-7

doi: 10.1016/j.nutres.2009.11.002

Nutrition Research
Volume 30, Issue 1 , Pages 32-39 , January 2010

Article Tools

* Image Usage & Resolution